Rxo annual free cash flow
2020
2021
2022
2023
2024
2025
Rxo Free Cash Flow (FCF) History (RXO)
Rxo reported −$8.0M in free cash flow for fiscal 2025, an increase of $49.0M from the previous fiscal year, with a free cash flow margin of −0.14%.
View full Rxo company overviewRxo free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$8.0M | $49.0M | — | −0.14% |
| 2024 | 2024-12-31 | −$57.0M | −$82.0M | — | −1.25% |
| 2023 | 2023-12-31 | $25.0M | −$228.0M | −90.12% | +0.64% |
| 2022 | 2022-12-31 | $253.0M | $137.0M | +118.10% | +5.28% |
| 2021 | 2021-12-31 | $116.0M | $138.0M | — | +2.47% |
| 2020 | 2020-12-31 | −$22.0M | — | — | −0.66% |
Rxo quarterly free cash flow
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$52.0M | −$61.0M | — | −2.93% |
| Q1 2026 | 2026-03-31 | −$24.0M | −$7.0M | — | −1.68% |
| Q4 2025 | 2025-12-31 | −$9.0M | $10.0M | — | −0.61% |
| Q3 2025 | 2025-09-30 | $9.0M | $27.0M | — | +0.63% |
| Q2 2025 | 2025-06-30 | $9.0M | $25.0M | — | +0.63% |
| Q1 2025 | 2025-03-31 | −$17.0M | −$13.0M | — | −1.19% |
| Q4 2024 | 2024-12-31 | −$19.0M | −$20.0M | — | −1.14% |
| Q3 2024 | 2024-09-30 | −$18.0M | −$4.0M | — | −1.73% |
| Q2 2024 | 2024-06-30 | −$16.0M | −$24.0M | — | −1.72% |
| Q1 2024 | 2024-03-31 | −$4.0M | −$34.0M | — | −0.44% |
| Q4 2023 | 2023-12-31 | $1.0M | −$57.0M | −98.28% | +0.10% |
| Q3 2023 | 2023-09-30 | −$14.0M | −$56.0M | — | −1.43% |
| Q2 2023 | 2023-06-30 | $8.0M | −$54.0M | −87.10% | +0.83% |
| Q1 2023 | 2023-03-31 | $30.0M | −$61.0M | −67.03% | +2.97% |
| Q4 2022 | 2022-12-31 | $58.0M | — | — | +5.18% |
| Q3 2022 | 2022-09-30 | $42.0M | — | — | +3.69% |
| Q2 2022 | 2022-06-30 | $62.0M | — | — | +5.06% |
| Q1 2022 | 2022-03-31 | $91.0M | — | — | +6.94% |
Rxo free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$22.0M to −$8.0M, a net increase of $14.0M. Rxo's latest reported quarter, Q2 2026, generated −$52.0M in free cash flow, a decrease of $61.0M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Rxo filings at SEC.gov ↗